The State of Metabolic Health in America, 2026 Baseline Edition · James M. Knox · DOI: 10.5281/zenodo.22772957 · Last reviewed: October 2026

Medicare Innovation

Series MV · The State of Metabolic Health in America, 2026 Baseline Edition

Overview

Medicare innovation models targeting metabolic and cardio-kidney-metabolic conditions, including the CMS ACCESS model design, payment mechanics, biomarker requirements, and the Medicare Diabetes Prevention Program scale gap.

This series contains 10 metrics in the 2026 Baseline Edition. Each metric cites a primary source. Where sources disagree, both figures and the reason for the discrepancy are documented rather than reconciled.

Metrics in This Series

Series MV metrics — The State of Metabolic Health in America, 2026 Baseline Edition
Metric IDMetricValueData YearPrimary Source
MV-01ACCESS model: clinical tracks addressing metabolic health2 of 42026CMS Innovation Center
MV-02ACCESS model: payment tied to biomarker achievementUp to 50%2026CMS Innovation Center
MV-03ACCESS model: minimum beneficiary target for full payment (Year 1)50%2026CMS Innovation Center
MV-04ACCESS model: planned duration10 years2026–2036CMS Innovation Center
MV-05Medicare Diabetes Prevention Program: active participants vs. eligible population941 vs. ~31.3 millionMost recently published countCMS; CDC National Diabetes Statistics Report
MV-06ACCESS model: required biomarker measure categories52026CMS Innovation Center
MV-07Medicare beneficiaries with diagnosed diabetes (approximate count)~17.7 million2024ASPE analysis
MV-08Special Needs Plans offering general supports for living72%2026CMS Medicare Advantage plan data
MV-09Special Needs Plans offering non-medical transportation36–37%2026CMS Medicare Advantage plan data
MV-10ACCESS model: participation typeVoluntary2026CMS Innovation Center

Methodological Notes

Metrics in this series draw on federal surveys, administrative data, and peer-reviewed literature. Where two sources report different figures for the same condition, both are documented with the reason for the discrepancy — typically differences in survey population, measurement method, or case definition.

See Methodology for the full source selection criteria, metric ID system, and conflict resolution approach.

Data Gaps in This Series

Specific data gaps for this series are documented on the Data Gaps page. The report names what is not measured rather than estimating missing values.

How to cite this page

Knox, J. M. (2026). Medicare Innovation (Series MV). In The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957

© 2026 James M. Knox. Figures may be reproduced with attribution: Knox, J. M. (2026). The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957 ISSN 3144-8178 (Online)